![](/images/general/no_picture/200_user.png)
Charles D Adams
Examiner (ID: 9147, Phone: (571)272-3938 , Office: P/2164 )
Most Active Art Unit | 2152 |
Art Unit(s) | 2164, 2152 |
Total Applications | 483 |
Issued Applications | 170 |
Pending Applications | 61 |
Abandoned Applications | 252 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11342399
[patent_doc_number] => 09526785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Pharmaceuticals for oral delivery'
[patent_app_type] => utility
[patent_app_number] => 15/184971
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 30755
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15184971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/184971 | Pharmaceuticals for oral delivery | Jun 15, 2016 | Issued |
Array
(
[id] => 11099522
[patent_doc_number] => 20160296492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'SELF-MICELLIZING FATTY ACIDS AND FATTY ACID ESTER COMPOSITIONS AND THEIR USE IN THE TREATMENT OF DISEASE STATES'
[patent_app_type] => utility
[patent_app_number] => 15/180430
[patent_app_country] => US
[patent_app_date] => 2016-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 38740
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15180430
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/180430 | SELF-MICELLIZING FATTY ACIDS AND FATTY ACID ESTER COMPOSITIONS AND THEIR USE IN THE TREATMENT OF DISEASE STATES | Jun 12, 2016 | Abandoned |
Array
(
[id] => 12831577
[patent_doc_number] => 20180169031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => CHITOSAN NANOFIBRES CONTAINING BIOACTIVE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/579886
[patent_app_country] => US
[patent_app_date] => 2016-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579886 | Chitosan nanofibers containing bioactive compounds | Jun 3, 2016 | Issued |
Array
(
[id] => 11335519
[patent_doc_number] => 20160361274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'MODIFIED RELEASE DOSAGE FORMS OF SKELETAL MUSCLE RELAXANTS'
[patent_app_type] => utility
[patent_app_number] => 15/165822
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5115
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15165822
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/165822 | MODIFIED RELEASE DOSAGE FORMS OF SKELETAL MUSCLE RELAXANTS | May 25, 2016 | Abandoned |
Array
(
[id] => 11053177
[patent_doc_number] => 20160250139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'HAIR TREATMENT AGENTS HAVING SUBSTITUTED SILICONE(S)'
[patent_app_type] => utility
[patent_app_number] => 15/151675
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11593
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15151675
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/151675 | HAIR TREATMENT AGENTS HAVING SUBSTITUTED SILICONE(S) | May 10, 2016 | Abandoned |
Array
(
[id] => 11046089
[patent_doc_number] => 20160243041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'GASTRIC RETENTIVE EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/147621
[patent_app_country] => US
[patent_app_date] => 2016-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 93615
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15147621
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/147621 | GASTRIC RETENTIVE EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS | May 4, 2016 | Abandoned |
Array
(
[id] => 11977324
[patent_doc_number] => 20170281478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'LIQUID LIPSTICK COMPOSITIONS CAPABLE OF FORMING A MULTILAYER STRUCTURE AFTER APPLICATION TO LIPS'
[patent_app_type] => utility
[patent_app_number] => 15/144622
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15086
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144622
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/144622 | Liquid lipstick compositions capable of forming a multilayer structure after application to lips | May 1, 2016 | Issued |
Array
(
[id] => 14636961
[patent_doc_number] => 10363207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => All-in-one skin-brightening formulations
[patent_app_type] => utility
[patent_app_number] => 15/143115
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3379
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15143115
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/143115 | All-in-one skin-brightening formulations | Apr 28, 2016 | Issued |
15/141055 | SHELF-STABLE WHIPPED FOAM-LIKE CONFECTIONARIES COMPRISING ERYTHRITOL AND ACTIVE INGREDIENTS | Apr 27, 2016 | Abandoned |
Array
(
[id] => 16443564
[patent_doc_number] => 10835467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Stabilizing mixture
[patent_app_type] => utility
[patent_app_number] => 15/742885
[patent_app_country] => US
[patent_app_date] => 2016-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7088
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15742885
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/742885 | Stabilizing mixture | Apr 25, 2016 | Issued |
Array
(
[id] => 16061171
[patent_doc_number] => 10689520
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Modified mineral-based filler comprising copper salts
[patent_app_type] => utility
[patent_app_number] => 15/564273
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22829
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564273
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/564273 | Modified mineral-based filler comprising copper salts | Apr 21, 2016 | Issued |
Array
(
[id] => 11031442
[patent_doc_number] => 20160228398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'OMEGA-3 FATTY ACID ESTER COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/134419
[patent_app_country] => US
[patent_app_date] => 2016-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 32443
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15134419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/134419 | OMEGA-3 FATTY ACID ESTER COMPOSITIONS | Apr 20, 2016 | Abandoned |
Array
(
[id] => 11031441
[patent_doc_number] => 20160228397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'OMEGA-3 FATTY ACID ESTER COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/134417
[patent_app_country] => US
[patent_app_date] => 2016-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 32528
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15134417
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/134417 | OMEGA-3 FATTY ACID ESTER COMPOSITIONS | Apr 20, 2016 | Abandoned |
Array
(
[id] => 14273845
[patent_doc_number] => 20190134207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Nicotine Delivery Product, Related Uses and Oral Dosage Forms, and Methods of Production
[patent_app_type] => utility
[patent_app_number] => 16/095145
[patent_app_country] => US
[patent_app_date] => 2016-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095145 | Nicotine delivery product, related uses and oral dosage forms, and methods of production | Apr 20, 2016 | Issued |
Array
(
[id] => 11038897
[patent_doc_number] => 20160235853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'OMEGA-3 FATTY ACID ESTER COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/132278
[patent_app_country] => US
[patent_app_date] => 2016-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 32471
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15132278
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/132278 | OMEGA-3 FATTY ACID ESTER COMPOSITIONS | Apr 18, 2016 | Abandoned |
Array
(
[id] => 11106084
[patent_doc_number] => 20160303053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'POLYMER-COATED THERAPEUTIC NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 15/130544
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7754
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15130544
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/130544 | POLYMER-COATED THERAPEUTIC NANOPARTICLES | Apr 14, 2016 | Abandoned |
Array
(
[id] => 12637602
[patent_doc_number] => 20180104364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => TEXAPHYRIN-PHOSPHOLIPID CONJUGATES AND METHODS OF PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 15/567294
[patent_app_country] => US
[patent_app_date] => 2016-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15567294
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/567294 | Texaphyrin-phospholipid conjugates and methods of preparing same | Apr 13, 2016 | Issued |
Array
(
[id] => 11102111
[patent_doc_number] => 20160299081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'BIO-ENABLED PLASMONIC SUPERSTRUCTURES WITH BUILT-IN AND ACCESSIBLE HOTSPOTS'
[patent_app_type] => utility
[patent_app_number] => 15/096505
[patent_app_country] => US
[patent_app_date] => 2016-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8532
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15096505
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/096505 | BIO-ENABLED PLASMONIC SUPERSTRUCTURES WITH BUILT-IN AND ACCESSIBLE HOTSPOTS | Apr 11, 2016 | Abandoned |
Array
(
[id] => 17378077
[patent_doc_number] => 11236074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject
[patent_app_type] => utility
[patent_app_number] => 15/562725
[patent_app_country] => US
[patent_app_date] => 2016-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 40
[patent_no_of_words] => 13678
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562725
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/562725 | Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject | Apr 5, 2016 | Issued |
Array
(
[id] => 11697578
[patent_doc_number] => 09687475
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-06-27
[patent_title] => 'Extended release pharmaceutical formulations with controlled impurity levels'
[patent_app_type] => utility
[patent_app_number] => 15/080305
[patent_app_country] => US
[patent_app_date] => 2016-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7683
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15080305
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/080305 | Extended release pharmaceutical formulations with controlled impurity levels | Mar 23, 2016 | Issued |